Arterial tortuosity syndrome: genes and variants
Explore variant evidence for Arterial tortuosity syndrome across 1 analyzed protein (SLC2A10). Linked ClinVar records include 12 pathogenic or likely pathogenic variants, 144 variants of uncertain significance and 26 with conflicting classifications.
Coverage includes proteins already analyzed in CATVariant, not every gene involved in this condition. Database links are associations, not an assessment of clinical gene–disease validity. Computable evidence prioritizes variants for expert review and does not reclassify them. Counts refer to the selected disease label.
Data updated 2026-11-04. Automated aggregation, not a clinical review date.
Download variant evidence (CSV)
Genes linked to Arterial tortuosity syndrome
SLC2A10: Solute carrier family 2, facilitated glucose transporter member 10
GLUT10, a transporter implicated in the intracellular movement of dehydroascorbic acid, an oxidized form of vitamin C. It helps maintain vascular connective tissues, and biallelic loss-of-function variants cause arterial tortuosity syndrome.
12 ClinVar pathogenic / likely pathogenic and 170 uncertain variants in SLC2A10 have source records linked to Arterial tortuosity syndrome. Association strength is not clinical gene validity.
ClinVar pathogenic and likely pathogenic variants linked to Arterial tortuosity syndrome
| Variant | Position | Protein part | Clinical label |
|---|---|---|---|
| SLC2A10 R231Q | 231 | Cytoplasmic | Pathogenic / likely pathogenic (★★) |
| SLC2A10 R231W | 231 | Cytoplasmic | Pathogenic / likely pathogenic (★★) |
| SLC2A10 S81R | 81 | Transmembrane | Pathogenic / likely pathogenic (★★) |
| SLC2A10 Q243K | 243 | Transmembrane | Pathogenic / likely pathogenic (★★) |
| SLC2A10 L300W | 300 | Transmembrane | Pathogenic / likely pathogenic (★★) |
| SLC2A10 G426W | 426 | Transmembrane | Pathogenic / likely pathogenic (★★) |
| SLC2A10 G23D | 23 | Transmembrane | Pathogenic / likely pathogenic (★) |
| SLC2A10 G23V | 23 | Transmembrane | Pathogenic / likely pathogenic (★) |
| SLC2A10 R132L | 132 | Cytoplasmic | Pathogenic / likely pathogenic (★) |
| SLC2A10 G445E | 445 | Cytoplasmic | Pathogenic / likely pathogenic (★) |
| SLC2A10 C304W | 304 | Transmembrane | Pathogenic / likely pathogenic (★) |
| SLC2A10 R132W | 132 | Cytoplasmic | Pathogenic / likely pathogenic |
Uncertain variants prioritized for review in Arterial tortuosity syndrome
| Variant | Position | Protein part | Clinical label | Evidence |
|---|---|---|---|---|
| SLC2A10 G23S | 23 | Transmembrane | Conflicting reports (★) | +7: 2 other pathogenic changes within 3 positions; G23D at the same position is pathogenic; seen in 2e-06 of gnomAD DNA copies; REVEL 0.912 |
| SLC2A10 G445R | 445 | Cytoplasmic | Uncertain (★★) | +7: in a 3D region that tolerates change poorly (1R); G445E at the same position is pathogenic; seen in 6.8e-07 of gnomAD DNA copies; REVEL 0.883 |
| SLC2A10 R132Q | 132 | Cytoplasmic | Conflicting reports (★) | +6: 2 other pathogenic changes within 3 positions; R132L at the same position is pathogenic; REVEL 0.897 |
Which prediction tools work for Arterial tortuosity syndrome
Observed separation of ClinVar pathogenic / likely pathogenic from benign / likely benign variants (AUROC × 100). This benchmark is not a clinical recommendation.
- CATVariant: 100 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- REVEL: 100 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- AlphaMissense: 100 out of 100
- PolyPhen-2: 100 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- SIFT: 100 out of 100
- MetaLR: 100 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- MetaSVM: 100 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- MutPred: 100 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- VARITY: 100 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- ESM1b (LLR): 100 out of 100
- CADD: 100 out of 100
- phastCons: 93 out of 100
- phyloP: 90 out of 100
- Pangolin: 61 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- SpliceAI: 48 out of 100 (learned from overlapping clinical labels, so this is optimistic)
Diseases related to Arterial tortuosity syndrome
- Familial thoracic aortic aneurysm and aortic dissection, also linked to SLC2A10
- Familial aortopathy, also linked to SLC2A10
- Familial hemophagocytic lymphohistiocytosis, also linked to SLC2A10
Frequently asked questions
Which genes have records linked to Arterial tortuosity syndrome?
This view contains 1 analyzed proteins: SLC2A10. Links come from clinical records and association databases. They do not imply that every listed gene is a validated cause, and missing genes may not yet be analyzed.
What do the clinical classifications mean?
Linked records include 12 pathogenic or likely pathogenic variants, 144 variants of uncertain significance and 26 with conflicting classifications. Labels summarize source records; multi-condition records may not make a separate assertion for this disease. Check the original record and review status.
Does the evidence score change a VUS classification?
No. 3 VUS or conflicting variants reach the likely-pathogenic points range on the computable criteria available here. This is a research prioritization signal, not a clinical classification. Patient, family and other required evidence may be missing.
Can I download the variant evidence?
Download the CSV for all 207 variants in the selected disease scope, including clinical labels, review status, evidence criteria, predictor scores, functional measurements and population frequency where available.
About this data
Variant–disease links come from ClinVar, Open Targets and UniProt, pooled from eligible public CATVariant analyses of each human protein. Evidence scores use the ACMG/AMP Bayesian points scale with computable criteria only (position among known disease variants, rarity in gnomAD, calibrated predictors, deep mutational scanning); there is no family or patient data, so they prioritise variants for expert review and never classify them.
Download every variant as CSV · Browse all diseases · Methods · About the Center